159 related articles for article (PubMed ID: 21983358)
1. The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus.
Denzler KL; Schriewer J; Parker S; Werner C; Hartzler H; Hembrador E; Huynh T; Holechek S; Buller RM; Jacobs BL
Vaccine; 2011 Dec; 29(52):9691-6. PubMed ID: 21983358
[TBL] [Abstract][Full Text] [Related]
2. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.
Denzler KL; Babas T; Rippeon A; Huynh T; Fukushima N; Rhodes L; Silvera PM; Jacobs BL
Vaccine; 2011 Dec; 29(52):9684-90. PubMed ID: 22001879
[TBL] [Abstract][Full Text] [Related]
3. The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus.
Denzler KL; Rice AD; MacNeill AL; Fukushima N; Lindsey SF; Wallace G; Burrage AM; Smith AJ; Manning BR; Swetnam DM; Gray SA; Moyer RW; Jacobs BL
Vaccine; 2011 Oct; 29(44):7659-69. PubMed ID: 21840358
[TBL] [Abstract][Full Text] [Related]
4. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.
Vijaysri S; Jentarra G; Heck MC; Mercer AA; McInnes CJ; Jacobs BL
Vaccine; 2008 Jan; 26(5):664-76. PubMed ID: 18096276
[TBL] [Abstract][Full Text] [Related]
5. A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.
Xiao Y; Aldaz-Carroll L; Ortiz AM; Whitbeck JC; Alexander E; Lou H; Davis HL; Braciale TJ; Eisenberg RJ; Cohen GH; Isaacs SN
Vaccine; 2007 Jan; 25(7):1214-24. PubMed ID: 17098336
[TBL] [Abstract][Full Text] [Related]
6. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
[TBL] [Abstract][Full Text] [Related]
7. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.
Paran N; Lustig S; Zvi A; Erez N; Israely T; Melamed S; Politi B; Ben-Nathan D; Schneider P; Lachmi B; Israeli O; Stein D; Levin R; Olshevsky U
Virol J; 2013 Jul; 10():229. PubMed ID: 23842430
[TBL] [Abstract][Full Text] [Related]
8. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination.
Jentarra GM; Heck MC; Youn JW; Kibler K; Langland JO; Baskin CR; Ananieva O; Chang Y; Jacobs BL
Vaccine; 2008 Jun; 26(23):2860-72. PubMed ID: 18455281
[TBL] [Abstract][Full Text] [Related]
9. Ectromelia virus lacking the E3L ortholog is replication-defective and nonpathogenic but does induce protective immunity in a mouse strain susceptible to lethal mousepox.
Frey TR; Forsyth KS; Sheehan MM; De Haven BC; Pevarnik JG; Hand ES; Pizzorno MC; Eisenlohr LC; Hersperger AR
Virology; 2018 May; 518():335-348. PubMed ID: 29602068
[TBL] [Abstract][Full Text] [Related]
10. A single vaccination with non-replicating MVA at birth induces both immediate and long-term protective immune responses.
Cheminay C; Körner J; Bernig C; Brückel M; Feigl M; Schletz M; Suter M; Chaplin P; Volkmann A
Vaccine; 2018 Apr; 36(18):2427-2434. PubMed ID: 29599088
[TBL] [Abstract][Full Text] [Related]
11. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
[TBL] [Abstract][Full Text] [Related]
12. Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity.
Hersperger AR; Siciliano NA; Eisenlohr LC
J Virol; 2012 Jul; 86(13):7298-309. PubMed ID: 22532670
[TBL] [Abstract][Full Text] [Related]
13. The Pathogenesis and Immunobiology of Mousepox.
Sigal LJ
Adv Immunol; 2016; 129():251-76. PubMed ID: 26791861
[TBL] [Abstract][Full Text] [Related]
14. Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.
Midgley CM; Putz MM; Weber JN; Smith GL
J Gen Virol; 2008 Dec; 89(Pt 12):2992-2997. PubMed ID: 19008384
[TBL] [Abstract][Full Text] [Related]
15. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
Wyatt LS; Earl PL; Eller LA; Moss B
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
[TBL] [Abstract][Full Text] [Related]
16. TLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines.
Israely T; Melamed S; Achdout H; Erez N; Politi B; Waner T; Lustig S; Paran N
PLoS One; 2014; 9(10):e110545. PubMed ID: 25350003
[TBL] [Abstract][Full Text] [Related]
17. The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.
Coulibaly S; Brühl P; Mayrhofer J; Schmid K; Gerencer M; Falkner FG
Virology; 2005 Oct; 341(1):91-101. PubMed ID: 16061267
[TBL] [Abstract][Full Text] [Related]
18. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.
Brandt T; Heck MC; Vijaysri S; Jentarra GM; Cameron JM; Jacobs BL
Virology; 2005 Mar; 333(2):263-70. PubMed ID: 15721360
[TBL] [Abstract][Full Text] [Related]
19. [The resistance of a maternally-derived immunity of baby mice against mousepox--experiments regarding a special possibility of immunization with orthopox viruses (author's transl)].
Munz E; Reimann M; Kaufmann R
Zentralbl Bakteriol B; 1979; 169(5-6):495-509. PubMed ID: 232602
[TBL] [Abstract][Full Text] [Related]
20. Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus.
Parker S; Crump R; Foster S; Hartzler H; Hembrador E; Lanier ER; Painter G; Schriewer J; Trost LC; Buller RM
Antiviral Res; 2014 Nov; 111():42-52. PubMed ID: 25128688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]